CERTAL
LIVE

Serial Number

79105109

Owner

QIAGEN GMBH

Attorney

Victoria Friedman

Filing Date

Aug 3, 2011

Add to watchlist:

No watchlists yet
View on USPTO

CERTAL Trademark

Serial Number: 79105109 • Registration: 4200573

CERTAL is a trademark filed by QIAGEN GMBH on August 3, 2011. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics). The application is currently registered and active.

Owner Contact Info

QIAGEN GMBH (211 trademarks)

HILDEN D-4010 , DE

Entity Type: 03

Trademark Details

Filing Date

August 3, 2011

Registration Date

September 4, 2012

Published for Opposition

June 19, 2012

Goods & Services

Scientific [ apparatus, instruments and ] equipment, in particular for research and experimentation purposes, [and laboratory apparatus, measuring apparatus and instruments ] in the nature of chromatography columns, [ robots ] [ and preprogrammed smart cards for [ protein, ] DNA and RNA purification protocols, ] [ and for the use of medical and veterinary diagnostic preparations,] in particular for sample preparation, [the modification and manipulation of cells, ] and for the marking, separating, identifying, quantifying, isolating, purifying, duplicating and/or analysis of biopolymers, and for identifying contamination through biomolecules, in particular nucleic acids, [ proteins, ] macromolecules and biologically active substances, in particular nucleic acids from biological or biochemical sample material, all the aforesaid goods included in this class

[Diagnostic preparations for medical purposes; diagnostic preparations for medical and veterinary use, in particular for sample preparation, the modification and manipulation of cells, and for conducting the marking, separating, identifying, quantifying, isolating, purifying, duplicating and/or analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, chemical, biochemical and biotechnological preparations, in particular diagnostic reagents and solvents for medical and veterinary use for sample preparation, the modification and manipulation of cells, and for conducting marking, separating, identifying, quantifying, isolating, purifying, duplicating and/or analysis methods for biopolymers, and for identifying contamination through biomolecules, in particular nucleic acids, proteins, macromolecules and biologically active substances for diagnostic purposes; kits containing medical and veterinary diagnostic preparations, in particular for sample preparation, the modification and manipulation of cells, and for the marking, separating, identifying, quantifying, isolating, purifying, duplicating and/or analysis of biopolymers, and for identifying contamination through biomolecules, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular nucleic acids from biological or biochemical sample material]

Chemical, biochemical and biotechnological products used in industry and science, namely, nucleic acids, enzymes, polymerases, reagents for staining and marking, molecular probes, buffer, aqueous and non-aqueous solutions of alcohols and salts, distilled and purified water, silica in powdered, granulate [and gel ]form and magnetic particles in fluid form, reagents and solvents for sample preparation, [the modification and manipulation of cells,] and for conducting marking, separating, identifying, quantifying, isolating, purifying, duplicating and/or analysis methods for biopolymers, in particular nucleic acids, [proteins,] macromolecules and biologically active substances, and for identifying contamination through biomolecules; namely, reagents for research purposes; kits containing chemicals for sample preparation, [the modification and manipulation of cells,] and for the marking, separating, identifying, quantifying, isolating, purifying, duplicating and/or analysis of biopolymers, and for identifying contamination through biomolecules, in particular nucleic acids, [proteins,] macromolecules and biologically active substances, in particular nucleic acids from biological or biochemical sample material for laboratory or research use

Filing History

PARTIAL INVALIDATION PROCESSED BY THE IB
Nov 26, 2023 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Oct 25, 2023 INPS
INVALIDATION PROCESSED
Oct 25, 2023 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Oct 18, 2023 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Feb 19, 2023 NA71
REGISTERED-SEC.71 ACCEPTED
Feb 18, 2023 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 13, 2023 APRE
TEAS SECTION 71 RECEIVED
Aug 8, 2022 ES71
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Sep 4, 2021 REM4
INTERNATIONAL REGISTRATION RENEWED
Aug 19, 2021 RNWL
PARTIAL INVALIDATION PROCESSED BY THE IB
Oct 18, 2019 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Jul 26, 2019 INPS
INVALIDATION PROCESSED
Jul 26, 2019 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jun 11, 2019 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Oct 11, 2018 NA75
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
Oct 11, 2018 C75P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 17, 2018 APRE
TEAS SECTION 71 & 15 RECEIVED
Aug 31, 2018 ES75
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Sep 4, 2017 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 23, 2012 FINO
NOTIFICATION PROCESSED BY IB
Dec 10, 2012 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Dec 5, 2012 FICS
FINAL DISPOSITION PROCESSED
Dec 5, 2012 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 4, 2012 FICR
REGISTERED-PRINCIPAL REGISTER
Sep 4, 2012 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 19, 2012 NPUB
PUBLISHED FOR OPPOSITION
Jun 19, 2012 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 30, 2012 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
May 30, 2012 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 30, 2012 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 16, 2012 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
May 16, 2012 CNSA
EXAMINER'S AMENDMENT ENTERED
May 15, 2012 XAEC
ASSIGNED TO LIE
May 15, 2012 ALIE
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 14, 2012 GNEN
EXAMINERS AMENDMENT E-MAILED
May 14, 2012 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 14, 2012 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 12, 2012 GNFN
FINAL REFUSAL E-MAILED
Apr 12, 2012 GNFR
FINAL REFUSAL WRITTEN
Apr 12, 2012 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 16, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 15, 2012 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 15, 2012 TROA
REFUSAL PROCESSED BY IB
Dec 24, 2011 RFNT
APPLICATION FILING RECEIPT MAILED
Dec 9, 2011 MAFR
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 7, 2011 RFCS
REFUSAL PROCESSED BY MPU
Dec 7, 2011 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 7, 2011 RFCR
NON-FINAL ACTION WRITTEN
Dec 6, 2011 CNRT
ASSIGNED TO EXAMINER
Dec 5, 2011 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 5, 2011 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 1, 2011 REPR